For the vast majority of cases of coronary artery disease, the treatment options are typically limited to angioplasty alone or with stents or coronary artery bypass grafting. Aside from the advent of new device and equipment technologies to perform coronary artery bypass via catheter or otherwise in minimally invasive formats (such as minimally invasive direct coronary artery bypass, or MIDCAB), the market for the treatment of coronary artery bypass is largely represented by interventional cardiology, comprised of the following products:
Download a copy of the Coronary Medical Devices Market White Paper and learn more about the innovation and market growth areas within the coronary artery disease technologies.